AccuraGen Secures $40,000,000 Series B Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1455 Adams Dr. Menlo Park, CA 94025 USA
  • Company Description
    We have developed a high-sensitivity, next-generation sequencing-based system for the the detection of cancer mutations in miniscule concentrations of circulating cell-free DNA (cfDNA) in blood.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Decheng Capital
  • Venture Investor
  • Venture Investor
    Junson Capital

Trending on Xconomy